131 related articles for article (PubMed ID: 22264987)
21. Methodological studies of orofacial aesthetics, orofacial function and oral health-related quality of life.
Larsson P
Swed Dent J Suppl; 2010; (204):11-98. PubMed ID: 20623943
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
23. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
24. Psychospiritual well-being and symptom distress in women with breast cancer.
Manning-Walsh JK
Oncol Nurs Forum; 2005 May; 32(3):543. PubMed ID: 15897928
[TBL] [Abstract][Full Text] [Related]
25. Improving breast cancer care through a regional quality collaborative.
Breslin TM; Caughran J; Pettinga J; Wesen C; Mehringer A; Yin H; Share D; Silver SM
Surgery; 2011 Oct; 150(4):635-42. PubMed ID: 22000174
[TBL] [Abstract][Full Text] [Related]
26. Pain, psychological distress, health status, and coping in patients with breast cancer scheduled for autotransplantation.
Gaston-Johansson F; Ohly KV; Fall-Dickson JM; Nanda JP; Kennedy MJ
Oncol Nurs Forum; 1999 Sep; 26(8):1337-45. PubMed ID: 10497773
[TBL] [Abstract][Full Text] [Related]
27. Validation of the functional assessment of cancer therapy--lung symptom index-12 (FLSI-12).
Eton DT; Cella D; Yount SE; Davis KM
Lung Cancer; 2007 Sep; 57(3):339-47. PubMed ID: 17485135
[TBL] [Abstract][Full Text] [Related]
28. Development of a symptom index for patients with primary brain tumors.
Lai JS; Jensen SE; Beaumont JL; Abernethy AP; Jacobsen PB; Syrjala K; Raizer JJ; Cella D
Value Health; 2014; 17(1):62-9. PubMed ID: 24438718
[TBL] [Abstract][Full Text] [Related]
29. Development and initial validation of the NCCN/FACT symptom index for advanced kidney cancer.
Rothrock NE; Jensen SE; Beaumont JL; Abernethy AP; Jacobsen PB; Syrjala K; Cella D
Value Health; 2013; 16(5):789-96. PubMed ID: 23947972
[TBL] [Abstract][Full Text] [Related]
30. The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research.
Yanez B; Pearman T; Lis CG; Beaumont JL; Cella D
Ann Oncol; 2013 Apr; 24(4):1073-8. PubMed ID: 23136235
[TBL] [Abstract][Full Text] [Related]
31. Symptom burden clusters: a challenge for targeted symptom management. A longitudinal study examining symptom burden clusters in breast cancer.
Kenne Sarenmalm E; Browall M; Gaston-Johansson F
J Pain Symptom Manage; 2014 Apr; 47(4):731-41. PubMed ID: 23916827
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).
Butt Z; Parikh ND; Beaumont JL; Rosenbloom SK; Syrjala KL; Abernethy AP; Benson AB; Cella D
Cancer; 2012 Dec; 118(23):5997-6004. PubMed ID: 22605658
[TBL] [Abstract][Full Text] [Related]
33. The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites.
Cella D; Neubauer N; Thomas J; Kutner J; Seiden MV
Gynecol Oncol; 2013 Feb; 128(2):187-90. PubMed ID: 23159815
[TBL] [Abstract][Full Text] [Related]
34. Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients.
Hollen PJ; Msaouel P; Gralla RJ
Breast Cancer Res Treat; 2015 Jun; 151(3):679-86. PubMed ID: 25981897
[TBL] [Abstract][Full Text] [Related]
35. Future trends in patient-reported outcomes assessment for patients with advanced-stage lung cancer receiving targeted therapy.
Eton DT; Yost KJ; Cella D
Clin Lung Cancer; 2006 Sep; 8(2):99-109. PubMed ID: 17026810
[TBL] [Abstract][Full Text] [Related]
36. A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy - Lymphoma Symptom Index.
Hlubocky FJ; Webster K; Beaumont J; Cashy J; Paul D; Abernethy A; Syrjala KL; Von Roenn J; Cella D
Leuk Lymphoma; 2013 Sep; 54(9):1942-6. PubMed ID: 23320888
[TBL] [Abstract][Full Text] [Related]
37. A brief symptom index for advanced lung cancer.
Yount S; Beaumont J; Rosenbloom S; Cella D; Patel J; Hensing T; Jacobsen PB; Syrjala K; Abernethy AP
Clin Lung Cancer; 2012 Jan; 13(1):14-23. PubMed ID: 21729652
[TBL] [Abstract][Full Text] [Related]
38. The measurement of symptoms and side effects in clinical trials of chronic pain.
Katz NP
Contemp Clin Trials; 2012 Sep; 33(5):903-11. PubMed ID: 22561389
[TBL] [Abstract][Full Text] [Related]
39. The development of the Canberra symptom scorecard: a tool to monitor the physical symptoms of patients with advanced tumours.
Barresi MJ; Shadbolt B; Byrne D; Stuart-Harris R
BMC Cancer; 2003 Dec; 3():32. PubMed ID: 14678564
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Smith KL; Zhao F; Mayer IA; Tevaarwerk AJ; Garcia SF; Arteaga CL; Symmans WF; Park BH; Burnette BL; Makower DF; Block M; Morley KA; Jani CR; Mescher C; Dewani SJ; Brown-Glaberman U; Flaum LE; Mayer EL; Sikov WM; Rodler ET; DeMichele AM; Sparano JA; Wolff AC; Miller KD; Wagner LI
Cancer; 2024 May; 130(10):1747-1757. PubMed ID: 38236702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
